AI Terminal
TRISTEL PLC
Regulatory Filings • Feb 26, 2024
7990_rns_2024-02-26_9508d2f6-e860-4227-8633-70693be64e4d.html
Regulatory Filings
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 3374E
Tristel PLC
26 February 2024
TRISTEL plc
("Tristel", the "Company", or the "Group")
UK and EU regulatory approval update for surface disinfection system
Sustainable alternative to commonly used pre-wetted plastic wipes to become available in Europe
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products utilising proprietary chlorine dioxide technology, announces that all reviews under the Medical Devices Regulation 2002 ("UK MDR") and the European Union Medical Device Regulation 2017/745 ("EU MDR") for approval of the Company's TANK ClO₂ Sporicidal Disinfectant system have been successfully concluded and a positive recommendation for UKCA and MDR certification has been made.
The TANK system and accompanying capsules are the newest additions to the Cache range, which provides sporicidal surface disinfection in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.
Following MDR approvals Tristel will be able to accelerate sales activity for this product throughout Europe and across geographies that recognise the high standard of safety and quality demonstrated by products conforming to the new EU MDR. The Directors believe that approval, will give Tristel the opportunity to deliver significant growth in sales of the Cache product range going forward, targeting a largely untapped sporicidal surface disinfection market. The Company expects to officially launch these latest products in Europe before the current financial year end on 30 June 2024.
For the year ended 30 June 2023 revenues from the Cache range totalled £3.3m, representing 9.2% of total annual turnover.
About TANK ClO₂ Sporicidal Disinfectant and the Cache range (https://thecachecollection.com)
TANK ClO₂ Sporicidal Disinfectant is a storage and distribution system powered by ClO₂ sporicidal disinfectant capsules. One TANK ClO₂ Sporicidal Disinfectant capsule makes 10 litres of sporicidal solution, which is the same as 2,000 sporicidal wipes wetted with 5ml of liquid. Rather than relying on convenience products that do harm once they are disposed of, TANK uses plastic thoughtfully. The core components are reusable, and all the plastic items within the system are recyclable. Users can apply TANK ClO₂ Sporicidal Disinfectant working solution with a Doser, Foamer or Sprayer, and reduce plastic waste by pairing TANK working solution with any dry wipe.
The TANK ClO₂ Sporicidal Disinfectant system
The broader Cache product range for sporicidal surface disinfection
For further information on the TANK ClO₂ Sporicidal Disinfectant system please view the product brochure here:
Paul Swinney, CEO of Tristel, commented: "Whilst our Cache product range is intended for environmental surfaces, many of the surfaces in a hospital setting are considered medical devices and so it is key for any disinfection products to comply with the new EU Medical Device Regulation. It is a very significant achievement to have concluded all reviews successfully and we expect to receive our recommendation for certification from our Notified Body very shortly. Conformity with MDR will allow us to apply CE marking to these new products and gives us the opportunity to deliver significant growth in sales of the Cache product range going forward."
For further information please contact:
| Tristel plc | Tel: 01638 721 500 |
| Paul Swinney, Chief Executive Officer | www.investors.tristel.com |
| Liz Dixon, Chief Financial Officer | |
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
| Paul McManus | Mob: 07980 541 893 |
| Charlotte Edgar | Mob: 07884 664 686 |
| Cavendish Capital Markets Ltd | Tel: 020 7220 0500 |
| Geoff Nash / Charlie Beeson (Corporate Finance) | |
| Sunila de Silva (ECM) |
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
REAGZGZZNFRGDZM